BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22385880)

  • 1. Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we under-treating our patients?
    Roth-Yelinek B
    Eur J Intern Med; 2012 Apr; 23(3):236-9. PubMed ID: 22385880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we over-treating our patients?
    Vardi M; Haran M
    Eur J Intern Med; 2012 Apr; 23(3):231-5. PubMed ID: 22385879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
    Ageno W; Spyropoulos AC; Turpie AG
    Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
    Harrington DW
    Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism risk and thromboprophylaxis among hospitalized patients: data from the Turkish arm of the ENDORSE study.
    Ongen G; Yılmaz A; Cirak AK; Ersoy CY; Erden F; Altıntaş F; Yıldırım C; Güven H; Demir A; Kaynar L; Bastacı N; Demirtaş N
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):539-45. PubMed ID: 20829272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.
    Bâ SA; Badiane SB; Diop SN; Diouf FS; Fall D; Ka MM; Kane A; Ndiaye M;
    Arch Cardiovasc Dis; 2011 Oct; 104(10):493-501. PubMed ID: 22044701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvement.
    Stevens SM; Douketis JD
    Clin Chest Med; 2010 Dec; 31(4):675-89. PubMed ID: 21047575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
    Amin AN; Girard F; Samama MM
    Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
    Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
    Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
    Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
    N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in patients hospitalized in internal medicine wards.
    Campanini M; Lunati F; Dugnani M; Re R
    Minerva Med; 2011 Feb; 102(1):93-101. PubMed ID: 21317851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.